JNJ
Johnson & Johnson
$242.25
-0.60%
Price vs EBIT Yield
Current Valuation
- EBIT Yield
- 3.34%
- EV/EBIT
- 29.9x
- P/E Ratio
- 22.1x
- PEG Ratio
- 1.70
EV/EBIT Averages
- Median (Fair Value)
- 18.0x
- Industry (Damodaran)
- 20.3x
- 1-Year Avg
- 29.6x
- 3-Year Avg
- 30.0x
- 5-Year Avg
- 30.0x
- Min / Max
- -102.6x / 30.5x
EBIT Growth
- YoY Growth
- 23.4%
- 3-Year CAGR
- 4.3%
- 5-Year CAGR
- 23.4%
- Current Margin
- 20.2%
Financial Snapshot
- Market Cap
- $587.32B
- Enterprise Value
- $612.45B
- Revenue (TTM)
- $94.19B
- Dividend Yield
- 2.12%
Valuation Context
vs 5-Year Average
-0%
Near average
EBIT Yield
3.34%
Moderate yield
vs Industry (Drugs (Pharmaceutica...)
47%
Above industry avg
Data Points
751
daily data points